Skip to content

Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity

A Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02371616
Enrollment
304
Registered
2015-02-25
Start date
2014-09-29
Completion date
2014-12-18
Last updated
2018-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentine Sensitivity

Brief summary

An 8 week clinical study to evaluate the ability of an experimental dentifrice containing calcium sodium phosphosilicate and sodium fluoride to provide relief from dentine hypersensitivity compared to a marketed dentifrice containing calcium sodium phosphosilicate and sodium monofluorophosphate.

Detailed description

A single centre, multi-site, randomised, examiner blind, two treatment, parallel group, non-inferiority design clinical study conducted in healthy subjects with self-reported and clinically diagnosed dentine hypersensitivity (DH). This study will compare the effectiveness of a test dentifrice containing 5% w/w calcium sodium phosphosilicate and fluoride as sodium fluoride to a commercially available dentifrice containing 5% w/w calcium sodium phosphosilicate and fluoride as sodium monofluorophosphate, in providing relief from DH after 4 and 8 weeks twice daily treatment.

Interventions

5% w/w calcium sodium phosphosilicate

1426 ppm fluoride as sodium fluoride

1426 ppm fluoride as sodium monofluorophosphate

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* subjects in good general health with no clinically significant/ relevant abnormalities of oral examination * pre-existing self reported and clinically diagnosed tooth sensitivity * at screening a minimum of 20 natural teeth and at least two accessible, non-adjacent teeth (incisors, canines or pre-molars) with signs of erosion or abrasion and/or facial/cervical gingival recession (EAR), with a Gingival Index ≤1 and clinical mobility ≤1, and with signs of DH as measured by qualifying evaporative (air) assessment * at baseline, a minimum of 2 non-adjacent accessible teeth (incisors, canines or premolars) with DH (qualifying tactile threshold Yeaple ≤ 20g, Schiff Sensitivity Score ≥ 2)

Exclusion criteria

* subjects with a known or suspected intolerance or hypersensitivity to study products * presence of chronic debilitating disease which could affect study outcomes * any condition which is causing dry mouth * use of an oral care product indicated for the relief of dentine hypersensitivity * participation in a DH treatment study in the 8 weeks prior to screening * taking daily doses of a medication/ treatment which could interfere with perception of pain or is causing dry mouth * require antibiotic prophylaxis for dental procedures * dental prophylaxis within 4 weeks of screening * treatment of periodontal disease within 12 months of screening+C60 * scaling or root planing within 3 months of screening * tooth bleaching within 8 weeks of screening * active caries or periodontitis * partial dentures, orthodontic appliances or dental implants which could affect study outcomes * Pregnant and breast-feeding females * Main Exclusions for Test Teeth: evidence of current or recent caries; treatment of decay within 12 months of screening; teeth with exposed dentine but with deep, defective or facial restorations; teeth used as abutments for fixed or removable partial dentures; teeth with full crowns or veneers, orthodontic bands or cracked enamel; sensitive teeth with contributing aetiologies other than erosion, abrasion or recession

Design outcomes

Primary

MeasureTime frameDescription
Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8At Baseline and Week 8Evaporative air sensitivity was assessed by examiner as a response to a 1 second application of air from a triple air dental syringe applied to the exposed dentine surface of hypersensitive tooth from a distance of approximately 1centimeter. Each participants rated the intensity of their response to the stimulus using a 100 millimeter (mm) VAS, were 0 represented no pain and 100 represented the worst pain imaginable. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth.

Secondary

MeasureTime frameDescription
Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 4At Baseline and Week 4Evaporative air sensitivity was assessed by examiner as a response to a 1 second application of air from a triple air dental syringe applied to the exposed dentine surface of hypersensitive tooth from a distance of approximately 1centimeter. Each participants rated the intensity of their response to the stimulus using a 100 mm VAS, were 0 represented no pain and 100 represented the worst pain imaginable. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth.
Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8At Baseline, Week 4 and Week 8Evaporative air sensitivity was measured by examiner as the participant's response to an evaporative air stimulus for each tooth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicate improvement in sensitivity. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth.
Change From Baseline in Tactile Threshold at Week 4 and Week 8At Baseline, Week 4 and Week 8Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentine surface from 10 g to an upper threshold of 80g in increments of 10 g. The tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth.

Countries

United Kingdom

Participant flow

Recruitment details

Participants were recruited at one center (three sites) in United Kingdom.

Pre-assignment details

A total of 731 participants were screened, out of which 304 participants were randomized. 427 participants were not randomized because 377 did not met the study criteria, 1 had adverse event, 3 were lost to follow up and 1 due to protocol violation, 5 withdrew consent and 40 participants were not randomized because of other reasons (not specified).

Participants by arm

ArmCount
Test Dentifrice
Test dentifrice containing 5% w/w calcium sodium phosphosilicate and 1426 ppm fluoride as sodium fluoride.
150
Comparator Dentifrice
Comparator dentifrice containing 5% w/w calcium sodium phosphosilicate and 1426 ppm fluoride as sodium monofluorophosphate.
154
Total304

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event01
Overall StudyOther (Not specified)15
Overall StudyProtocol Violation21
Overall StudyWithdrawal of Consent10

Baseline characteristics

CharacteristicTest DentifriceComparator DentifriceTotal
Age, Continuous41.1 years
STANDARD_DEVIATION 10.33
42.5 years
STANDARD_DEVIATION 9.43
41.9 years
STANDARD_DEVIATION 9.89
Sex: Female, Male
Female
122 Participants131 Participants253 Participants
Sex: Female, Male
Male
28 Participants23 Participants51 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1500 / 154
other
Total, other adverse events
51 / 15059 / 154
serious
Total, serious adverse events
0 / 1500 / 154

Outcome results

Primary

Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8

Evaporative air sensitivity was assessed by examiner as a response to a 1 second application of air from a triple air dental syringe applied to the exposed dentine surface of hypersensitive tooth from a distance of approximately 1centimeter. Each participants rated the intensity of their response to the stimulus using a 100 millimeter (mm) VAS, were 0 represented no pain and 100 represented the worst pain imaginable. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth.

Time frame: At Baseline and Week 8

Population: Analysis for this outcome was performed on per protocol (PP) population which is defined as all participants in the intent to treat (ITT) population who had at least one assessment of efficacy considered unaffected by protocol violations.

ArmMeasureGroupValue (MEAN)Dispersion
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8At Baseline53.05 score on a scaleStandard Deviation 20.873
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8At Week 831.62 score on a scaleStandard Deviation 24.194
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8Change from baseline at Week 8-21.50 score on a scaleStandard Deviation 22.231
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8At Baseline55.89 score on a scaleStandard Deviation 21.334
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8At Week 830.51 score on a scaleStandard Deviation 23.96
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8Change from baseline at Week 8-25.16 score on a scaleStandard Deviation 22.322
Comparison: Statistical analysis applies to change from baseline at week 8 for test and comparator dentifrice.p-value: 0.267895% CI: [-2.06, 7.4]ANCOVA
Secondary

Change From Baseline in Tactile Threshold at Week 4 and Week 8

Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentine surface from 10 g to an upper threshold of 80g in increments of 10 g. The tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth.

Time frame: At Baseline, Week 4 and Week 8

Population: Analysis for this outcome was performed on PP population which is defined as all participants in the ITT population who had at least one assessment of efficacy considered unaffected by protocol violations.

ArmMeasureGroupValue (MEAN)Dispersion
Test DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8At Week 425.45 gram (g)Standard Deviation 20.573
Test DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8At Week 832.88 gram (g)Standard Deviation 25.392
Test DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8Change from baseline at Week 412.72 gram (g)Standard Deviation 20.181
Test DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8Change from baseline at Week 820.10 gram (g)Standard Deviation 25.041
Test DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8At Baseline12.79 gram (g)Standard Deviation 3.419
Comparator DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8Change from baseline at Week 821.42 gram (g)Standard Deviation 24.45
Comparator DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8At Baseline12.18 gram (g)Standard Deviation 2.982
Comparator DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8At Week 423.61 gram (g)Standard Deviation 18.616
Comparator DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8Change from baseline at Week 411.42 gram (g)Standard Deviation 18.099
Comparator DentifriceChange From Baseline in Tactile Threshold at Week 4 and Week 8At Week 833.58 gram (g)Standard Deviation 24.84
Secondary

Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8

Evaporative air sensitivity was measured by examiner as the participant's response to an evaporative air stimulus for each tooth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicate improvement in sensitivity. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth.

Time frame: At Baseline, Week 4 and Week 8

Population: Analysis for this outcome was performed on PP population which is defined as all participants in the ITT population who had at least one assessment of efficacy considered unaffected by protocol violations.

ArmMeasureGroupValue (MEAN)Dispersion
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8At Week 42.13 score on a scaleStandard Deviation 0.771
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8At Week 81.65 score on a scaleStandard Deviation 0.99
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8Change from baseline at Week 4-0.59 score on a scaleStandard Deviation 0.689
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8Change from baseline at Week 8-1.08 score on a scaleStandard Deviation 0.922
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8At Baseline2.72 score on a scaleStandard Deviation 0.393
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8Change from baseline at Week 8-1.09 score on a scaleStandard Deviation 0.937
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8At Baseline2.68 score on a scaleStandard Deviation 0.4
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8At Week 42.11 score on a scaleStandard Deviation 0.832
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8Change from baseline at Week 4-0.57 score on a scaleStandard Deviation 0.745
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8At Week 81.58 score on a scaleStandard Deviation 1.002
Secondary

Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 4

Evaporative air sensitivity was assessed by examiner as a response to a 1 second application of air from a triple air dental syringe applied to the exposed dentine surface of hypersensitive tooth from a distance of approximately 1centimeter. Each participants rated the intensity of their response to the stimulus using a 100 mm VAS, were 0 represented no pain and 100 represented the worst pain imaginable. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth.

Time frame: At Baseline and Week 4

Population: Analysis for this outcome was performed on PP population which is defined as all participants in the ITT population who had at least one assessment of efficacy considered unaffected by protocol violations.

ArmMeasureGroupValue (MEAN)Dispersion
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 4At Week 440.71 score on a scaleStandard Deviation 22.828
Test DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 4Change from baseline at Week 4-12.12 score on a scaleStandard Deviation 18.438
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 4At Week 440.60 score on a scaleStandard Deviation 23.09
Comparator DentifriceMean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 4Change from baseline at Week 4-15.24 score on a scaleStandard Deviation 19.895

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026